No abstract available
Keywords:
Covid-19; PRES; SARS-CoV-2; Status epilepticus; Verapamil.
MeSH terms
-
Aged
-
Anemia / etiology
-
Anticoagulants / therapeutic use
-
Anticonvulsants / therapeutic use*
-
Antiviral Agents / therapeutic use
-
Betacoronavirus
-
COVID-19
-
COVID-19 Drug Treatment
-
Calcium Channel Blockers / therapeutic use*
-
Coronavirus Infections / complications
-
Coronavirus Infections / drug therapy
-
Coronavirus Infections / physiopathology*
-
Drug Combinations
-
Enzyme Inhibitors / therapeutic use
-
Humans
-
Hydroxychloroquine / therapeutic use
-
Lopinavir / therapeutic use
-
Lymphopenia / etiology
-
Male
-
Pandemics
-
Pneumonia, Viral / complications
-
Pneumonia, Viral / drug therapy
-
Pneumonia, Viral / physiopathology*
-
Posterior Leukoencephalopathy Syndrome / diagnostic imaging
-
Posterior Leukoencephalopathy Syndrome / etiology
-
Posterior Leukoencephalopathy Syndrome / physiopathology*
-
Ritonavir / therapeutic use
-
SARS-CoV-2
-
Status Epilepticus / drug therapy*
-
Status Epilepticus / etiology
-
Verapamil / therapeutic use*
Substances
-
Anticoagulants
-
Anticonvulsants
-
Antiviral Agents
-
Calcium Channel Blockers
-
Drug Combinations
-
Enzyme Inhibitors
-
lopinavir-ritonavir drug combination
-
Lopinavir
-
Hydroxychloroquine
-
Verapamil
-
Ritonavir